Department of Natural Product Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Ji'nan, Shandong, China.
Drug Discov Ther. 2022 Jul 20;16(3):105-111. doi: 10.5582/ddt.2022.01039. Epub 2022 Jun 25.
There are trillions of microorganisms in the human intestine. They can react to the intestinal microenvironment by metabolizing food or producing small molecular compounds to affect the host's digestive ability and resist the risk of infection and autoimmune diseases. Many studies have revealed that intestinal flora and its metabolites play an important role in human physiology and the development of diseases. Urolithins are kind of intestinal microbiota metabolites of ellagitannins (ETs) and ellagic acid (EA) with potent biological activity in vivo. However, different individuals have different intestinal flora. According to the different metabolites from ETs and EA, it is divided into three metabo-types including UM-A, UM-B and UM-0. This paper reviews the origin of urolithins, the urolithin producing microorganisms and the effects of urolithins on regulating intestinal diseases. This review will provide a theoretical basis for the regulation of urolithins in the homeostasis of intestinal flora and a reference for the scientific utilization of urolithins and foods rich in ETs and EA.
人类肠道中存在着数以万亿计的微生物。它们可以通过代谢食物或产生小分子化合物来对肠道微环境做出反应,从而影响宿主的消化能力,抵抗感染和自身免疫性疾病的风险。许多研究表明,肠道菌群及其代谢产物在人体生理学和疾病发展中发挥着重要作用。尿石素是鞣花单宁(ETs)和鞣花酸(EA)的肠道微生物群代谢物,具有很强的体内生物活性。然而,不同的个体有不同的肠道菌群。根据 ETs 和 EA 的不同代谢产物,它可分为 UM-A、UM-B 和 UM-0 三种代谢类型。本文综述了尿石素的来源、产生尿石素的微生物以及尿石素对调节肠道疾病的作用。这篇综述为调节肠道菌群内的尿石素稳态提供了理论基础,并为科学利用尿石素和富含 ETs 和 EA 的食物提供了参考。